Study Study Study
Subjects Analyzed (N = 303) Quarto II (N = 198) Quarto III (N = 105)
p-value
Age (years) Age (years) Age (years) Age (years) Age (years)
Mean ± SD (N) 65.5±9.7 (303) 66.1±10.2 (198) 64.5±8.4 (105) 0.048w
(Min, Median, Max) (29.0, 66.0, 94.0) (29.0, 67.0, 94.0) (40.0, 64.0, 82.0)
Gender, n/N (%) Gender, n/N (%) Gender, n/N (%) Gender, n/N (%) Gender, n/N (%)
Female 79/303 (26.1%) 52/198 (26.3%) 27/105 (25.7%) 0.918c
Male 224/303 (73.9%) 146/198 (73.7%) 78/105 (74.3%)
NYHa Class, n/N (%) NYHa Class, n/N (%) NYHa Class, n/N (%) NYHa Class, n/N (%) NYHa Class, n/N (%)
I 11/303 (3.6%) 5/198 (2.5%) 6/105 (5.7%) 0.002c
II 137/303 (45.2%) 77/198 (38.9%) 60/105 (57.1%)
III 150/303 (49.5%) 111/198 (56.1%) 39/105 (37.1%)
IV 5/303 (1.7%) 5/198 (2.5%) 0/105 (0.0%)
Type of Cardiomyopathy, n/N (%) Type of Cardiomyopathy, n/N (%) Type of Cardiomyopathy, n/N (%) Type of Cardiomyopathy, n/N (%) Type of Cardiomyopathy, n/N (%)
ISCHEMIC 124/303 (40.9%) 80/198 (40.4%) 44/105 (41.9%) 0.800c
NON-ISCHEMIC 179/303 (59.1%) 118/198 (59.6%) 61/105 (58.1%)
Medical History, n(%) Medical History, n(%) Medical History, n(%) Medical History, n(%) Medical History, n(%)
Unstable Angina 3/303 (1.0%) 2/198 (1.0%) 1/105 (1.0%) 0.961c
Hypertension 141/303 (46.5%) 69/198 (34.8%) 72/105 (68.6%) <0.001c
Alcoholic 12/303 (4.0%) 8/198 (4.0%) 4/105 (3.8%) 0.922c
Diabetes Mellitus 109/303 (36.0%) 64/198 (32.3%) 45/105 (42.9%) 0.069c
COPD 23/303 (7.6%) 13/198 (6.6%) 10/105 (9.5%) 0.355c
CABG 26/303 (8.6%) 14/198 (7.1%) 12/105 (11.4%) 0.197c
Hypertrophic 4/303 (1.3%) 3/198 (1.5%) 1/105 (1.0%) 0.683c
Dilated 129/303 (42.6%) 87/198 (43.9%) 42/105 (40.0%) 0.509c
Idiopatic 44/303 (14.5%) 32/198 (16.2%) 12/105 (11.4%) 0.266c
LVESV at Baseline (mL) LVESV at Baseline (mL) LVESV at Baseline (mL) LVESV at Baseline (mL) LVESV at Baseline (mL)
Mean ± SD (N) 146.0±72.3 (283) 155.2±75.1 (180) 129.8±64.4 (103) 0.003w
(Min, Median, Max) (22.0, 130.0, 545.0) (22.0, 141.5, 463.0) (41.7, 118.3, 545.0)
EF at Baseline(%) EF at Baseline(%) EF at Baseline(%) EF at Baseline(%) EF at Baseline(%)
Mean ± SD (N) 28.6±8.0 (292) 26.9±7.4 (189) 31.7±8.3 (103) <0.01t
(Min, Median, Max) (0.3, 29.0, 50.0) (0.3, 28.0, 46.7) (10.0, 33.0, 50.0)
t Two Sample t-test w Wilcoxon Rank Sum test c Chi-square test t Two Sample t-test w Wilcoxon Rank Sum test c Chi-square test t Two Sample t-test w Wilcoxon Rank Sum test c Chi-square test t Two Sample t-test w Wilcoxon Rank Sum test c Chi-square test t Two Sample t-test w Wilcoxon Rank Sum test c Chi-square test